Akışa dön
75/100 Bullish 16.07.2026 · 13:45 Finrend AI ⏱ 1 dk 👁 5 TR

Abbott Raises 2026 Profit Forecast on Strength in Diagnostics and Heart Devices

Abbott Laboratories has revised its 2026 profit forecast upward, driven by strong performance in its diagnostics and heart device segments. The company expects higher profitability in the coming period, particularly due to increased demand for cardiovascular products and diagnostic tests. Under the new forecast, Abbott raised its adjusted earnings per share for 2026 above previous expectations. This revision is seen as a reflection of the company's growth strategy, supported by R&D investments and operational efficiency improvements. Analysts note that Abbott's continuous innovation in its diagnostics division and its leading position in the heart device market strengthen the company's long-term growth potential. Notably, sales increases in products such as minimally invasive heart valves and glucose monitoring systems stand out. Company management aims for sustainable growth in the coming years, supported by strong cash flow and a balanced portfolio structure. This improvement in Abbott's 2026 profit forecast has been well received by investors. This is not investment advice.

📊 GOOGL — Piyasa Yorumu

▲ up · 60%

GOOGL stock is exhibiting a strong uptrend, with the RSI approaching overbought territory at 65.6. The MACD line remains above the signal line and in positive territory, indicating sustained short-term momentum. The price is trading above both the 20-day and 50-day moving averages, which are trending upward. Although the news headline is related to Abbott, it may have an indirect impact on the technology sector; however, it is not a direct catalyst for GOOGL. The uptrend may continue in the short term, but caution is advised due to overbought signals.

RSI 14
65.6
MACD
3.93
24h Δ
4.44%

📊 ABT — Piyasa Yorumu

▲ up · 70%

The news indicates that Abbott has raised its profit forecast, citing strong performance in its diagnostics and heart devices segments. This positive development could boost optimism for the stock. Technical indicators also support this view: although the RSI is near overbought territory at 74, the MACD is above the signal line and shows positive momentum. The price is trading well above the 20- and 50-day moving averages, with a 7.7% increase in the last 24 hours. However, the high RSI also brings a risk of a short-term correction, so the upward expectation should be tempered with cautious optimism.

RSI 14
74.2
MACD
0.87
24h Δ
7.74%
Canlı Grafikler

🔗 İlgili haberler

🧬 Buna benzer

AI tarafından yeniden derlenmiştir. Yatırım tavsiyesi değildir.